Indivior Plc (INDV) Jumps 22.8% on Impressive Earnings, Outlook

We recently published 10 Stocks With Surprising Gains. Time to Sell? Indivior PLC (NASDAQ:INDV) is one of the companies that stood stronger last week.

Indivior PLC soared by 22.81 percent week-on-week as investors took heart from its impressive earnings performance and a higher growth outlook for the year.

In an updated report last week, Indivior PLC (NASDAQ:INDV) said that it swung to a net income of $18 million in the second quarter of the year from a $97 million net loss in the same period last year. Net revenues inched up by 1 percent to $302 million from $299 million year-on-year, thanks to a strong performance in its Sublocade drug, supported by stable prices from its Suboxone drugs.

For the first half, Indivior PLC (NASDAQ:INDV) recorded a $65 million net profit, reversing a $36 million net loss in the same period last year. Revenues, however, dipped by 2.6 percent to $568 million from $583 million year-on-year.

Following the promising results, the company raised its net revenue guidance for full year 2025, now at a range of $1.03 billion to $1.08 billion, versus the $955 million to $1.025 billion previously.

While we acknowledge the potential of INDV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.